Connecticut Qualifying Conditions: Detailed Guide
What conditions qualify for medical marijuana in Connecticut?
Connecticut's Medical Marijuana Program recognizes over 30 qualifying conditions as defined by the Department of Consumer Protection. To qualify, you need a diagnosis from a Connecticut-licensed physician, physician assistant, or APRN. MMJ.com offers telehealth evaluations for $149.99 with same-day certification and a 100% money-back guarantee if not approved.## What is the complete list of Connecticut qualifying conditions?
Connecticut's Medical Marijuana Program, overseen by the Department of Consumer Protection, recognizes the following qualifying conditions for 2026:
Chronic Pain and Related Conditions
- Chronic Neuropathic Pain (persistent pain lasting 6+ months)
- Intractable Pain (pain unresponsive to conventional treatments)
- Complex Regional Pain Syndrome
- Fibromyalgia
Neurological Conditions
- Epilepsy and Seizure Disorders
- Multiple Sclerosis (MS)
- Parkinson's Disease
- Amyotrophic Lateral Sclerosis (ALS)
- Cerebral Palsy
- Tourette's Syndrome
- Spinal Muscular Atrophy
- Uncontrolled Intractable Seizure Disorder
Mental Health Conditions
- Post-Traumatic Stress Disorder (PTSD)
Cancer and Terminal Illness
- Cancer (pain, nausea, weight loss)
- Terminal Illness (end-of-life conditions)
- [Cachexia/Wasting Syndrome](/connecticut-medical-marijuana-card/qualifying-conditions/cachexia/)
Gastrointestinal Conditions
- Crohn's Disease
- Ulcerative Colitis
- Inflammatory Bowel Disease (IBD)
- Severe Nausea (non-pregnancy-related)
Infectious Diseases
- HIV/AIDS
- Hepatitis C
Other Qualifying Conditions
- Glaucoma
- Cystic Fibrosis
- Sickle Cell Disease
- Osteogenesis Imperfecta
- Severe Persistent Muscle Spasms (including spinal cord injuries)
- Spinal Cord Injury or Disease
About the Qualifying Medical Conditions
Below is information about each qualifying condition category and the research that informed Connecticut's decision to include them in the state program.
Cancer, HIV/AIDS, Hepatitis C, and Terminal Illness
These are approved qualifying conditions under Connecticut's medical marijuana program. Connecticut included these conditions based on research examining cannabinoid use among patients experiencing treatment-related symptoms.
Epilepsy and Seizure Disorders
Epilepsy and seizure disorders are approved qualifying conditions under Connecticut's medical marijuana program. Connecticut included these conditions based on clinical trial research examining CBD in patients with treatment-resistant epilepsy.
Multiple Sclerosis, Parkinson's Disease, and ALS
These neurological conditions are approved under Connecticut's medical marijuana program. Connecticut included these conditions based on clinical research examining cannabinoid use in patients with spasticity and motor symptoms.
PTSD
PTSD is an approved qualifying condition under Connecticut's medical marijuana program. Connecticut included this condition based on research examining cannabinoid use among patients with PTSD.
Chronic Pain, Fibromyalgia, and Neuropathic Pain
These pain conditions are approved under Connecticut's medical marijuana program. Connecticut included these conditions based on systematic reviews examining cannabinoid use among patients with chronic pain conditions.
Crohn's Disease, Ulcerative Colitis, and IBD
These gastrointestinal conditions are approved under Connecticut's medical marijuana program. Connecticut included these conditions based on clinical research examining cannabis use in patients with inflammatory bowel conditions.
Glaucoma
Glaucoma is an approved qualifying condition under Connecticut's medical marijuana program. Connecticut included this condition based on early research examining the relationship between cannabinoids and intraocular pressure.
Tourette's Syndrome
Tourette's Syndrome is an approved qualifying condition under Connecticut's medical marijuana program. Connecticut included this condition based on clinical research examining THC use in patients with Tourette's Syndrome.
Sickle Cell Disease
Sickle Cell Disease is an approved qualifying condition under Connecticut's medical marijuana program. Connecticut included this condition based on research examining cannabinoid use among patients with sickle cell-related symptoms.
Cachexia/Wasting Syndrome
Cachexia is an approved qualifying condition under Connecticut's medical marijuana program. Connecticut included this condition based on research examining dronabinol use in patients experiencing appetite and weight concerns.
Severe Nausea
Severe Nausea is an approved qualifying condition under Connecticut's medical marijuana program. Connecticut included this condition based on research examining cannabinoid use among patients experiencing nausea.
Muscle Spasms and Spinal Cord Conditions
Severe muscle spasms and spinal cord injuries are approved qualifying conditions under Connecticut's medical marijuana program. Connecticut included these conditions based on clinical research examining cannabinoid use in patients with spasticity.
Other Approved Conditions
Cerebral Palsy, Spinal Muscular Atrophy, Cystic Fibrosis, and Osteogenesis Imperfecta are approved qualifying conditions under Connecticut's medical marijuana program as determined by the Department of Consumer Protection.
Can I petition for a new qualifying condition in Connecticut?
Yes, Connecticut residents can petition the Department of Consumer Protection to add new medical conditions to the qualifying list. Each petition requires:
- Comprehensive medical documentation
- Scientific evidence supporting the petition
- Support from healthcare professionals
Petitions are typically reviewed within 180 days.
Medical Disclaimer
This page provides information about Connecticut's qualifying conditions for medical marijuana. The inclusion of a condition in Connecticut's program does not constitute medical advice or a guarantee of therapeutic benefit. Individual results vary. Potential side effects may include dizziness, sedation, and cognitive changes. Always consult a qualified healthcare provider before making medical decisions.
Reviewed by MMJ.com Medical Advisory Team Last Updated: December 17, 2025